John is the Vice President of Patient Solutions and Operational Excellence for J&J. He is responsible for leading the integrated operations strategy and execution of patient engagement services across J&J Innovative Medicines’ North America portfolio of brands.
Prior to this role, John led J&J’s readiness and response to IRA including defining strategy and execution of plans to navigate this new precedent setting government program
John brings extensive and diverse commercial and market access experience, with more than 30 years in the pharmaceutical industry. He has worked in multiple therapeutic areas, including Oncology, and has experience leading teams in commercial strategy, marketing, market access, operations, and patient services.
He holds a Master of Business Administration from Lehigh University and a bachelor’s degree in accounting from the University of Scranton.